| Date Filed | Type | Description |
| 05/26/2023 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.62, valued at
$9.3k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.|
Txns:
| Granted 1,922 shares
@ $0
Granted 4,805 options to buy
@ $0.4339, valued at
$2.1k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.8074, valued at
$32.3k
|
|
| 10/05/2020 |
3
| Cermak Elizabeth (Director) has filed a Form 3 on Moleculin Biotech, Inc. |
| 09/04/2018 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on SteadyMed Ltd.|
Txns:
| Disposed of 33,350 options to buy
@ $5.6, valued at
$186.8k
Disposed of 3,875 options to buy
@ $3.85, valued at
$14.9k
Disposed of 21,029 options to buy
@ $3.65, valued at
$76.8k
|
|
| 12/28/2017 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on SteadyMed Ltd.|
Txns:
| Granted 13,029 options to buy
@ $3.65, valued at
$47.6k
Granted 8,000 options to buy
@ $3.65, valued at
$29.2k
|
|
| 10/05/2016 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on SteadyMed Ltd. |
| 09/10/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/26/2012 |
4
| Cermak Elizabeth (EVP, Chief Commercial Officer) has filed a Form 4 on POZEN INC /NC|
Txns:
| Granted 21,000 shares
@ $0 |
|
| 03/16/2012 |
4
| Cermak Elizabeth (EVP, Chief Commercial Officer) has filed a Form 4 on POZEN INC /NC|
Txns:
| Granted 10,000 shares
@ $0
Granted 25,000 options to buy
@ $4.72, valued at
$118k
|
|
| 10/04/2011 |
4
| Cermak Elizabeth (EVP, Chief Commercial Officer) has filed a Form 4 on POZEN INC /NC|
Txns:
| Granted 28,000 shares
@ $2.41, valued at
$67.5k
Paid exercise price by delivering 3,030 shares
@ $2.41, valued at
$7.3k
|
|
| 03/16/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/31/2010 |
4
| Cermak Elizabeth (EVP, Chief Commercial Officer) has filed a Form 4 on POZEN INC /NC|
Txns:
| Granted 14,600 options to buy
@ $6.5, valued at
$94.9k
|
|
| 09/15/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2009 |
3
| Cermak Elizabeth (EVP, Chief Commercial Officer) has filed a Form 3 on POZEN INC /NC |